Comparative study of artesunate, ACTs and their combinants on the biochemical parameters of male guinea-pigs

African Journal of Biotechnology

Volumn 8, Issue 19, 2009, Pages 5059-5065

  Obianime, A W ^a   Aprioku, J S ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

ACT; Biochemical; Combinants; Phosphatase enzymes; Prostatic acid phosphatase

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ALKALINE PHOSPHATASE; AMODIAQUINE; ARTESUNATE; CHOLESTEROL; CREATININE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE; UREA; URIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; GUINEA PIG; NONHUMAN; UREA BLOOD LEVEL;

ARTESUNATE; CAVIA;

EID: 70350452396     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Babson LA, Greeley SJ, Coleman CM, Phillips GD (1966). Phenolphthalein Monophosphate as a Substrate for Serum Alkaline Phosphatase. Clin. Chem. 12: 482-490.
2. Bloch K, Schoenheimer R (1939). Studies in protein metabolism. The metabolic relation of creatine and creatinine studied with isotopic nitrogen. J. Biol. Chem. 131: 111-119.
3. Chu TM, Lin MF (1998). PSA and acid phosphatase in the diagnosis of prostate cancer. J. Clin. Ligand Assay, 21: 24-34.
4. Cotran KC (1999). Cellular Pathology. Robbins Pathologic basis of disease, Fifth Edition, Elsvier, UK, p, 40.
5. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D (2001). A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344(4): 299-302.
6. Fishman HW, Davidson MH (2006). Determination of Serum Acid Phosphatases. Method Biochem. Anal. 4: 257-284.
7. Fossati P, Prencipe L, Berti G (1980). Use of 3, 5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin. Chem. 26(2): 227-231
8. Gaspari F, Perico N, Matalone M, Signorini O, Azzollini N, Mister M, Remuzzi G (1998). Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J. Am. Soc. Nephrol. 9: 310-313.
9. Guerrero S, Zacharías J (1986). The effect of 4-aminoquinoline on frog atrial myocardium depolarized by potassium. Gen. Pharmacol. 17(1): 37-42.
10. Haynes RK (2001). Artemisinin and derivatives: The future for malaria treatment? Curr. Opin. Infect Dis. 14: 719-726.
11. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000). Uric Acid, A PerOxynitrite Scavenger, Inhibits CNS Inflammation, Blood-CNS Barrier Permeability Changes, And Tissue Damage In A Mouse Model Of MS. FASEB J. 14(5): 691-698. (Pubitemid 30198568)
12. Jefford CW (2001). Why artemisinin and certain synthetic peroxides are potent antimalarials: Implications for the mode of action. Curr. Med. Chem. 8: 1803-1826.
13. th ed; Lange; pp. 864-876.
14. Kim SH, Kim HJ, Kim TS (2003). Differential involvement of proteinkinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. Eur. J. Pharmacol. 482(1-3): 67-76
15. Knapp CM, Constantinescu CS, Tan JH, McLean R, Cherryman GR, Gottlob I (2004). Serum uric acid levels in optic neuritis. Mult. Scler. 10(3): 278-280
16. Kyes S, Horrocks P, Newbold C (2001). Antigenic variation at the infected red cell surface in malaria. Annu. Rev. microbial. 55: 673-707.
17. Lin MF, Lee CL, Wojcieszyn JW, Wang MC, Valenzuela LA, Murphy GP, Chu TM (1980). Fundamental biochemical and immunological aspects of prostatic acid phosphatase. Prostate, 1: 415-425.
18. McIntosh HM, Olliaro P (2000). Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst. Rev. 2: CD000256.
19. Meshnick SR (1994). Free radicals and antioxidants. Lancet, 344: 1441-1442.
20. Mollica MP, Iossa V, Liverini V, Soboll S (1998). Oxygen consumption and biosynthetic function in perfused liver from rats at different stages of development. Cell. Mol. life sci. (CMLS). 54: 1277-1282.
21. Mouton R, Holder K (2006). Laboratory tests of renal function. Anaesthesia intensive care medicine. 7(7): 240-243.
22. Nam W, Tak J, Ryu J, Jung M, Yook J, Kim H, Cha I (2006). Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Med. Vet. Health Sci./Oncol. Radiotherapy, 29(4): 335-340.
23. Nankivell BJ (2001). Creatinine clearance and the assessment of renal function. Aust. Prescr. 24: 15-17.
24. Ngokere AA, Ngokere TC, Ikwudinma AP (2004). Acute study of Histomorphological and Biochemical changes caused by Artesunate in Visceral Organs of the Rabbit. J. Exp. Clin. Anat. 3(2): 11-16.
25. Nishizuka Y (1984). Turnover of inositol phospholipids and signal transduction. Science, 225(4668): 1365-1370
26. Nosten F, White NJ (2007). Artemisinin-Based Combination Treatment of Falciparum Malaria. Am. J. Trop. Med. Hyg. 77(6): 181-192.
27. Nwanjo HU, Oze G (2007). Acute Hepatotocixity Following Administration Of Artesunate In Guinea Pigs. Internet J. Toxicol. 4(1).
28. Perrone R, Madias N, Levy A (1992). Serum Creatinine as an index of renal function: New insights into old concepts. Clin. Chem. 38: 1933-1953.
29. Price RN, Van VM, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White NJ (1998). Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria. Am. J. Trop. Med. Hyg. 59: 883-888
30. Robert KM, Daryl KG, Peter AM, Victor WR (2000). Harper's Biochemistry (25th ed.). Appleton: Lange, pp. 169-170, 648-649.
31. Roeschlau P, Bernt E, Gruber WJ (1974). Enzymatic determination of total cholesterol in serum. Clin. Chem. Clin. Biochem. 12(5): 226.
32. Sachs J, Malaney P (2002). The economic and social burden of malaria. Nature, 415: 680-685
33. Sharma V (2005). Therapeutic Drugs for Targeting Chloroquine Resistance in Malaria. Mini Rev. Med. Chem. 5(4): 337-351.
34. Tietz NW, Pruden EL, Siggard-Anderson O (1986). Electrolytes, Blood Gasses and Acid base Balance in Textbook of Clinical chem. Saunders. Philaddephia, pp. 1188-1196.
35. Trinder P (1969).Enzymatic determination of total serum cholesterol. Ann. Clin. Biochem. 6: p. 24.
36. Traynor J, Geddes CC, Fox JG (2006). How to measure renal function in clinical practice BMJ. 333: 733-737.
37. Wannamethee SG, Shaper AG, Perry IJ (1997). Serum creatinine concentration and risk of cardiovascular disease, a possible marker for increased risk of stroke. Stroke, 28: 557-563.
38. Wang MC, Papsidero LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM (1981). Prostate antigen: a new potential marker for prostatic cancer. Prostate, 2: 89-96.
39. Wartenberg M, Wolf S, Budde P, Grünheck F, Acker H, Hescheler J, Wartenberg G, Sauer H (2003). The Antimalaria Agent Artemisinin Exerts Antiangiogenic Effects in Mouse Embryonic Stem Cell-Derived Embryoid Bodies. Lab. Invest. 83: 1647-1655.
40. Weatherbum MW (1967). Phenylhypochlorite reaction for determination of ammonia. Analytica Chemica, 39: p. 971.
41. White NJ (1999). Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354: 739-749.
42. White NJ (1997). Assessment of the pharmacodynamic properties of anti-malaria drugs in vivo. Antimicrob. Agents Chemother. 41: 1413-1422.
43. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR (2002). Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2: 209-218.
44. World Health Organization (1998). Malaria Chemotherapy. Tech. Reg. Ser. Geneva.
45. World Health Organization (2000). Management of severe malaria. A practical handbook.
46. Wyss M, Kaddurah-Daouk R (2000). Creatine and Creatinine Metabolism Physiol. Rev. 80: 1107-1213.
47. Yam LT (1974). Clinical significance of the human acid phosphatases: a review. Am. J. Med. 56: 604-616.